NCT/Study#
NCT06179160 /
INCB161734-101
Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors with KRAS G12D Mutation.
DISEASE GROUP:
Solid Tumors
current phase:
Phase I
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
